Table 2.
Clinical characteristics of 39 HER2+ patients
| Sample | Date Diagnosis | Stage Diagnosis | Trastuzumab | Statusa |
| 1 | 2003 | IIA | No | NED |
| 2 | 2003 | IIB | No | DOD |
| 3 | 2003 | IIA | Yes | NED |
| 4 | 2003 | IIA | No | NED |
| 5 | 2005 | I | Yes | NED |
| 6 | 2003 | IIA | Yes | DOD |
| 7 | 2004 | IIA | No | NED |
| 8 | 2004 | I | No | NED |
| 9 | 2004 | IV | Yes | AWD |
| 10 | 2004 | IIIA | Yes | AWD |
| 11 | 2004 | IIIA | Yes | NED |
| 12 | 2004 | IIIC | Yes | AWD |
| 13 | 2004 | I | No | NED |
| 14 | 2004 | I | No | NED |
| 15 | 2004 | IIIC | Yes | NED |
| 16 | 2004 | IIIA | Yes | NED |
| 17 | 2001 | IIB | No | NED |
| 18 | 2001 | I | No | NED |
| 19 | 2002 | I | No | NED |
| 20 | 2002 | IIA | No | UNK |
| 21 | 2002 | IIIA | No | NED |
| 22 | 2002 | I | No | NED |
| 23 | 2002 | I | No | NED |
| 24 | 2002 | IIB | No | NED |
| 25 | 2003 | IIIC | No | NED |
| 26 | 2003 | IIA | No | NED |
| 27 | 2005 | I | No | NED |
| 28 | 2004 | IIA | No | NED |
| 29 | 2005 | IIIA | No | NED |
| 30 | 2005 | I | No | NED |
| 31 | 1996 | IIIB | No | DOC |
| 32 | 2002 | I | Unknown | NED |
| 33 | 2003 | I | Yes | NED |
| 34 | 1992 | IIA | No | NED |
| 35 | 1993 | IIIA | No | DOD |
| 36 | 1994 | I | No | NED |
| 37 | 1995 | I | No | DOC |
| 38 | 1995 | I | No | DOD |
| 39 | 1996 | IIB | No | NED |
aAWD = alive with disease, DOC = dead other causes, DOD = dead of disease, NED = no evidence of disease, UNK = status unknown